Ernst Hoyer, Utah Medical Products, Inc. (UTMD)’s insider Sold 1,529 Shares; Last Week Heritage Insurance Holdings, Inc. (HRTG) Coverage

Among 7 analysts covering Heritage Insurance Holdings (NYSE:HRTG), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Heritage Insurance Holdings had 18 analyst reports since August 7, 2015 according to SRatingsIntel. Keefe Bruyette & Woods maintained Heritage Insurance Holdings, Inc. (NYSE:HRTG) rating on Thursday, August 17. Keefe Bruyette & Woods has “Buy” rating and $17.0 target. The firm has “Buy” rating by Sandler O’Neill given on Friday, September 23. The firm has “Buy” rating given on Friday, November 3 by Citigroup. The stock of Heritage Insurance Holdings, Inc. (NYSE:HRTG) has “Buy” rating given on Tuesday, October 17 by Citigroup. The firm has “Buy” rating given on Friday, August 7 by Citigroup. The rating was upgraded by JMP Securities on Tuesday, October 20 to “Market Outperform”. Wood maintained Heritage Insurance Holdings, Inc. (NYSE:HRTG) on Monday, June 13 with “Outperform” rating. The firm earned “Buy” rating on Friday, June 2 by Keefe Bruyette & Woods. The firm earned “Buy” rating on Wednesday, November 1 by SunTrust. The stock of Heritage Insurance Holdings, Inc. (NYSE:HRTG) earned “Hold” rating by JMP Securities on Monday, January 22. See Heritage Insurance Holdings, Inc. (NYSE:HRTG) latest ratings:

22/01/2018 Broker: JMP Securities Rating: Hold Downgrade
21/12/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $21.0 Maintain
04/12/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $20.0 Maintain
03/11/2017 Broker: Citigroup Rating: Buy Old Target: $18 New Target: $19 Maintain
01/11/2017 Broker: SunTrust Rating: Buy New Target: $18.0 Maintain
17/10/2017 Broker: Citigroup Rating: Buy Old Target: $17 New Target: $18 Maintain
26/09/2017 Broker: SunTrust Rating: Buy New Target: $18.0
20/09/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $17.0 Maintain
17/08/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $17.0 Maintain

In an electronic form submitted to the (SEC), it was published that the director of Utah Medical Products Inc Ernst Hoyer, an insider in spotlight, made sold with a broker for 1,529 shares of the stock exchange listed company, worth near $134,673 US Dollars using the average stock value of $88.1 US Dollars. Ernst is trying to silently decrease his company’s share, same as he did in the last month. He unloaded another 49 shares worth $4,459 USD. Ernst Hoyer now indirectly possess 51247 shares. He also directly possess 0 shares. In total he holds a stake of 1.38%.

Heritage Insurance Holdings, Inc., through its subsidiaries, provides personal and commercial residential insurance products. The company has market cap of $427.35 million. The firm offers personal residential insurance for single-family homeowners and condominium owners; rental property insurance; and commercial residential insurance, as well as insurance policies for residential wind insurance in the state of Florida, North Carolina, South Carolina, Hawaii, Georgia, Alabama, and Mississippi. It has a 446.94 P/E ratio. As of December 31, 2016, it had approximately 319,676 personal residential policies and 3,625 commercial residential policies.

The stock decreased 1.59% or $0.26 during the last trading session, reaching $16.09. About 188,800 shares traded. Heritage Insurance Holdings, Inc. (NYSE:HRTG) has declined 6.57% since February 13, 2017 and is downtrending. It has underperformed by 23.27% the S&P500.

Utah Medical Products, Inc. develops, makes, and distributes medical devices for the healthcare industry worldwide. The company has market cap of $319.97 million. It provides fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system. It has a 37.79 P/E ratio. The firm also offers umbilical vessel catheters; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; URI-CATH, a urinary drainage system; and MYELO-NATE, a lumbar sampling kit.

Since February 2, 2018, it had 0 insider purchases, and 1 sale for $4,459 activity. Another trade for 49 shares valued at $4,459 was sold by HOYER ERNST G.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: